期刊文献+

基质金属蛋白酶-2和CD105在胃癌中的表达及其相关性的研究 被引量:1

Expression and relationship of matrix metailoproteinase-2 and CD105 in gastric carcinoma
暂未订购
导出
摘要 目的 检测基质金属蛋白酶-2(Matrix metalloproteinase-2,MMP-2)及CD105标记的血管密度(microvessel density,MVD)在胃癌中的表达,探讨二者在胃癌发生发展及转移中的作用.方法 采用免疫组织化学方法,分别检测MMP-2和CD105标记的微血管密度在不同临床病理特征之间的关系.结果 胃癌组织中MMP-2表达阳性率为66.7%,明显高于正常胃黏膜组织,胃癌中的血管密度明显高于正常胃黏膜组织,MMP-2及血管密度在胃癌中的表达均与分化程度、浸润深度及淋巴结转移有关,MMP-2阳性的血管密度明显高于阴性组.结论 MMP-2和CD105参与胃癌的发生和进展,MMP-2能促进胃癌中CD105阳性的血管生成. Objective To detect the expression of matrix metalloproteinase-2 (MMP-2)and mierovessel density ( MVD ) marked by CD105 in gastric carcinoma and investigate their relation in pathogenesis, development and metastasis in primary gastric carcinoma. Methods The expression of MMP-2 and MVD was detected in tissues with different pathological characters by immunological histological chemistry. Results The positive rate of MMP-2 expression in gastric carcinoma was 66.7%, which was signifiantly higher than that in the normal gastric tissues. The MVD in gastric carcinoma was upregulated compared with the normal tissues. The expression of MMP-2 and MVD in gastric carcinoma was correlated with differentiation,penetrating depth and lymph node metastasis. The MVD was upregulated in tissues with positive MMP-2 expression compared with the controls. Conclusion MMP-2 and CD105 may be involved in the occurrence and development of gastric carcinoma. MMP-2 can promote the angiogenesis which expresses CD105 in gastric carcinoma.
出处 《临床外科杂志》 2013年第5期352-354,共3页 Journal of Clinical Surgery
基金 河北省教育厅高等学校科学研究计划课题资助项目(Z2011317) 唐山市科学技术研究与发展计划课题资助(10130269c)
关键词 胃癌 MMP-2 CD105 血管生成 免疫组织化学 primary gastric carcinoma MMP-2 CD105 angiogenesis immunological histological chemistry
  • 相关文献

参考文献5

二级参考文献18

  • 1刘韬,马岩,张锐.基质金属蛋白酶与恶性肿瘤侵袭和转移关系的研究进展[J].吉林大学学报(医学版),2004,30(4):662-664. 被引量:10
  • 2彭利,左连富,王顺祥,王晓玲,张萌,张凤瑞,唐瑞峰.肝癌组织中COX-2、VEGF、MMP-2、MMP-9的表达及相互关系的免疫组化研究[J].实用肿瘤杂志,2005,20(2):134-136. 被引量:20
  • 3Christopoulos TA,Papageorgakopoulou N,Ravazoula P,et al.Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma[J].Oncol Rep,2007;18(4):855-60.
  • 4Gao ZL,Zhang C,Du GY,et al.Clinical significance of changes in tumor markers,extracellular matrix,MMP-9 and VEGF in patients with gastric carcinoma[J].Hepatogastroenterology,2007;54(77):1591-5.
  • 5Nomiya T,Nemoto K,Nakata E,et al.Expression of thymidine phosphorylase and VEGF in esophageal squamous cell carcinoma[J].Oncol Rep,2006;15(6):1497-501.
  • 6Matsumoto M,Natsugoe S,Okumura H,et al.Overexpression of vascular endothelial growth factor-C correlates with lymph node micrometastasis in submucosal esophageal cancer[J].J Gastrointest Surg,2006;10(7):1016-22.
  • 7Noriyuki M,Sumi T,Zhi X,et al.Vascular endothelial growth factor,matrix metalloproteinases,and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women[J].Int J Oncol,2007;31(3):531-6.
  • 8Haupt LM,Irving RE,Weinstein SR,et al.Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material[J].Mol Cell Probes,2008;22(2):83-9.
  • 9Pesta M,Topolcan O,Holubec L Jr,et al.Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples[J].Anticancer Res,2007;27(4A):1863-7.
  • 10Klisho EV,Savenkova OV,Kondakova IV,et al.Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma[J].Vopr Onkol,2007;53(1):26-31.

共引文献26

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部